Usdin Karen, Kumari Daman
Section on Gene Structure and Disease, Laboratory of Cell and Molecular Biology, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD, USA.
Front Genet. 2015 Jun 3;6:192. doi: 10.3389/fgene.2015.00192. eCollection 2015.
The fragile X-related disorders are members of the Repeat Expansion Diseases, a group of genetic conditions resulting from an expansion in the size of a tandem repeat tract at a specific genetic locus. The repeat responsible for disease pathology in the fragile X-related disorders is CGG/CCG and the repeat tract is located in the 5' UTR of the FMR1 gene, whose protein product FMRP, is important for the proper translation of dendritic mRNAs in response to synaptic activation. There are two different pathological FMR1 allele classes that are distinguished only by the number of repeats. Premutation alleles have 55-200 repeats and confer risk of fragile X-associated tremor/ataxia syndrome and fragile X-associated primary ovarian insufficiency. Full mutation alleles on the other hand have >200 repeats and result in fragile X syndrome, a disorder that affects learning and behavior. Different symptoms are seen in carriers of premutation and full mutation alleles because the repeat number has paradoxical effects on gene expression: Epigenetic changes increase transcription from premutation alleles and decrease transcription from full mutation alleles. This review will cover what is currently known about the mechanisms responsible for these changes in FMR1 expression and how they may relate to other Repeat Expansion Diseases that also show repeat-mediated changes in gene expression.
脆性X相关疾病是重复序列扩增疾病的成员,这是一组由特定基因座处串联重复序列长度扩增导致的遗传疾病。导致脆性X相关疾病病理的重复序列是CGG/CCG,该重复序列位于FMR1基因的5'非翻译区,其蛋白质产物FMRP对于响应突触激活时树突状mRNA的正确翻译很重要。有两种不同的病理性FMR1等位基因类别,仅通过重复序列数量来区分。前突变等位基因有55 - 200个重复序列,会导致脆性X相关震颤/共济失调综合征和脆性X相关原发性卵巢功能不全的风险。另一方面,全突变等位基因有超过200个重复序列,会导致脆性X综合征,这是一种影响学习和行为的疾病。前突变和全突变等位基因携带者会出现不同症状,因为重复序列数量对基因表达有矛盾的影响:表观遗传变化增加前突变等位基因的转录,减少全突变等位基因的转录。本综述将涵盖目前已知的FMR1表达变化机制,以及它们如何与其他也表现出重复序列介导的基因表达变化的重复序列扩增疾病相关。